{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:46:20Z","timestamp":1772743580179,"version":"3.50.1"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/mot.0b013e3283651b21","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:13:16Z","timestamp":1377879196000},"page":"555-562","source":"Crossref","is-referenced-by-count":18,"title":["The consequences of pediatric renal transplantation on bone metabolism and growth"],"prefix":"10.1097","volume":"18","author":[{"given":"Justine","family":"Bacchetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Dem\u00e8de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20211004","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00467-007-0490-6","article-title":"A structural approach to the assessment of fracture risk in children and adolescents with chronic kidney disease.","volume":"22","author":"Leonard","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R2-10-20211004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2006050427","article-title":"Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression.","volume":"18","author":"Cunningham","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R3-10-20211004","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/ndt\/gfs299","article-title":"The consequences of chronic kidney disease on bone metabolism and growth in children.","volume":"27","author":"Bacchetta","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R4-10-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease.","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-10-20211004","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-10-20211004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R7-10-20211004","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats.","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"R8-10-20211004","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R9-10-20211004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.1740","article-title":"Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.","volume":"28","author":"Bacchetta","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R10-10-20211004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-10-20211004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","article-title":"Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients.","volume":"25","author":"Priemel","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R12-10-20211004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-10-20211004","first-page":"1486","article-title":"Posttransplant hypophosphatemia: Tertiary Hyper-Phosphatoninism Kidney","volume":"70","author":"Bhan","year":"2006","journal-title":"international"},{"key":"R14-10-20211004","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.06380611","article-title":"Renal phosphate loss in long-term kidney transplantation.","volume":"7","author":"Sirilak","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-10-20211004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ki.1981.153","article-title":"Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children.","volume":"20","author":"Garabedian","year":"1981","journal-title":"Kidney Int"},{"key":"R16-10-20211004","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.transproceed.2009.07.087","article-title":"1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation.","volume":"41","author":"Falkiewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"R17-10-20211004","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.transproceed.2011.01.083","article-title":"Influence of 1,25-dihydroxyvitamin D3 on human leukocyte antigen-DR expression, macrophage infiltration, and graft survival in renal allografts.","volume":"43","author":"Ozdemir","year":"2011","journal-title":"Transplant Proc"},{"key":"R19-10-20211004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R20-10-20211004","first-page":"3379","article-title":"Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23 Nephrol Dial T","volume":"26","author":"Wesseling-Perry","year":"2011","journal-title":"ransplant"},{"key":"R22-10-20211004","first-page":"73","article-title":"Are fibroblast growth factor 23 concentrations in renal transplant patients different from nontransplanted chronic kidney disease patients Pediatr T","volume":"16","author":"Filler","year":"2012","journal-title":"ransplant"},{"key":"R23-10-20211004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","article-title":"Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.","volume":"86","author":"Bergua","year":"2008","journal-title":"Transplantation"},{"key":"R24-10-20211004","first-page":"1140","article-title":"Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study.","volume":"74","author":"Nordal","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-10-20211004","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R26-10-20211004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","article-title":"Bone disease in patients with long-term renal transplantation and normal renal function.","volume":"36","author":"Carlini","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R27-10-20211004","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcn\/87.2.431","article-title":"Vitamin D status in kidney transplant patients: need for intensified routine supplementation.","volume":"87","author":"Ewers","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R28-10-20211004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00198-004-1653-y","article-title":"Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.","volume":"16","author":"Roe","year":"2005","journal-title":"Osteoporos Int"},{"key":"R29-10-20211004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0012.2011.01524.x","article-title":"Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.","volume":"26","author":"Evenepoel","year":"2011","journal-title":"Clin Transplant"},{"key":"R30-10-20211004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e31822d87e8","article-title":"Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.","volume":"92","author":"Zitt","year":"2011","journal-title":"Transplantation"},{"key":"R31-10-20211004","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","article-title":"Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.","volume":"94","author":"Cohen","year":"2012","journal-title":"Transplantation"},{"key":"R32-10-20211004","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ki.1995.335","article-title":"Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.","volume":"48","author":"Salusky","year":"1995","journal-title":"Kidney Int"},{"key":"R34-10-20211004","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1359\/jbmr.1999.14.10.1680","article-title":"Growth retardation in children with chronic renal failure.","volume":"14","author":"Kuizon","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"Suppl 3","key":"R36-10-20211004","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.2215\/CJN.00460107","article-title":"Technical approach to iliac crest biopsy.","volume":"3","author":"Hernandez","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R37-10-20211004","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R38-10-20211004","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1523-1755.1998.00866.x","article-title":"Bone disease in children and adolescents undergoing successful renal transplantation.","volume":"53","author":"Sanchez","year":"1998","journal-title":"Kidney Int"},{"key":"R39-10-20211004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00467-002-0824-3","article-title":"Growth hormone and the skeleton in pediatric renal allograft recipients.","volume":"17","author":"Sanchez","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"R40-10-20211004","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"R41-10-20211004","first-page":"209","article-title":"Osteoporosis due to glucocorticoid use in children with chronic illness.","volume":"64","author":"Ward","year":"2005","journal-title":"Horm Res"},{"issue":"Suppl 1","key":"R42-10-20211004","first-page":"33","article-title":"Mechanisms of steroid impairment of growth.","volume":"58","author":"Hochberg","year":"2002","journal-title":"Horm Res"},{"key":"R43-10-20211004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000116623","article-title":"Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway.","volume":"77","author":"Perez","year":"2008","journal-title":"Digestion"},{"key":"R44-10-20211004","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1097\/01.ASN.0000028640.78526.0F","article-title":"Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2.","volume":"13","author":"Ferrari","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R45-10-20211004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","article-title":"Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.","volume":"280","author":"Hofbauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-10-20211004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bone.2003.05.003","article-title":"Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.","volume":"34","author":"Fukunaga","year":"2004","journal-title":"Bone"},{"key":"R47-10-20211004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jbmr.5650100119","article-title":"Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.","volume":"10","author":"Bryer","year":"1995","journal-title":"J Bone Miner Res"},{"key":"R48-10-20211004","first-page":"44","article-title":"Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management J Renal N","volume":"19","author":"Bacchetta","year":"2009","journal-title":"utr"},{"key":"R49-10-20211004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-009-1248-0","article-title":"Limitations of dual X-ray absorptiometry in children with chronic kidney disease.","volume":"25","author":"Weber","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R51-10-20211004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1399-3046.2003.00060.x","article-title":"Decreased bone mineral density in the pediatric renal transplant population.","volume":"7","author":"Acott","year":"2003","journal-title":"Pediatr Transplant"},{"key":"R52-10-20211004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004670050464","article-title":"Weight-height-related bone mineral density is not reduced after renal transplantation.","volume":"12","author":"Klaus","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R53-10-20211004","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00247-007-0450-0","article-title":"Pediatric DXA: clinical applications.","volume":"37","author":"Binkovitz","year":"2007","journal-title":"Pediatr Radiol"},{"key":"R54-10-20211004","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00467-011-1829-6","article-title":"CKD-MBD after renal transplantation.","volume":"26","author":"Wesseling-Perry","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R55-10-20211004","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1681\/ASN.2011050480","article-title":"Bone density and cortical structure after pediatric renal transplantation.","volume":"23","author":"Terpstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R56-10-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00467-010-1745-1","article-title":"Bone assessment in children with chronic kidney disease: data from two new bone imaging techniques in a single-center pilot study.","volume":"26","author":"Bacchetta","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R57-10-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-007-0527-x","article-title":"Growth hormone axis in chronic kidney disease.","volume":"23","author":"Mahesh","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R59-10-20211004","first-page":"CD003264","article-title":"Growth hormone for children with chronic kidney disease.","volume":"3","author":"Vimalachandra","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R60-10-20211004","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00467-010-1450-0","article-title":"First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report.","volume":"25","author":"Mahan","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R61-10-20211004","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00467-008-0787-0","article-title":"Growth after renal transplantation.","volume":"24","author":"Harambat","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R62-10-20211004","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","article-title":"Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.","volume":"21","author":"Mahan","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R63-10-20211004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","article-title":"Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.","volume":"21","author":"Klaus","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R64-10-20211004","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jcem.82.4.3893","article-title":"Reduced concentration of serum growth hormone-binding protein in children with chronic renal failure: correlation with growth hormone insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.","volume":"82","author":"Tonshoff","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-10-20211004","first-page":"S106","article-title":"Derangements of the somatotropic hormone axis in chronic renal failure.","volume":"58","author":"Tonshoff","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"R66-10-20211004","first-page":"2978","article-title":"Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.","volume":"82","author":"Powell","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-10-20211004","first-page":"1654","article-title":"The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.","volume":"83","author":"Powell","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R68-10-20211004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-200107150-00006","article-title":"Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.","volume":"72","author":"Sarwal","year":"2001","journal-title":"Transplantation"},{"key":"R69-10-20211004","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.TP.0000092950.54184.67","article-title":"Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.","volume":"76","author":"Sarwal","year":"2003","journal-title":"Transplantation"},{"key":"R70-10-20211004","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","article-title":"A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.","volume":"10","author":"Grenda","year":"2010","journal-title":"Am J Transplant"},{"key":"R71-10-20211004","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00467-011-1811-3","article-title":"Growth of kidney-transplanted pediatric patients treated with sirolimus.","volume":"26","author":"Gonzalez","year":"2011","journal-title":"Pediatric nephrology"},{"key":"R72-10-20211004","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ki.2010.173","article-title":"Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate.","volume":"78","author":"Alvarez-Garcia","year":"2010","journal-title":"Kidney Int"},{"key":"R73-10-20211004","doi-asserted-by":"crossref","first-page":"e34788","DOI":"10.1371\/journal.pone.0034788","article-title":"Growth hormone improves growth retardation induced by rapamycin without blocking its antiproliferative and antiangiogenic effects on rat growth plate.","volume":"7","author":"Alvarez-Garcia","year":"2012","journal-title":"PLoS One"},{"key":"R74-10-20211004","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2011111115","article-title":"Cardiovascular disease in children with chronic kidney disease.","volume":"23","author":"Mitsnefes","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R75-10-20211004","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R76-10-20211004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00467-009-1337-0","article-title":"Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD).","volume":"25","author":"Hruska","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R77-10-20211004","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/ndt\/gfh303","article-title":"Natural history of vascular calcification in dialysis and transplant patients.","volume":"19","author":"Moe","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R78-10-20211004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.0000133412.53089.26","article-title":"Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation.","volume":"110","author":"Mitsnefes","year":"2004","journal-title":"Circulation"},{"key":"R79-10-20211004","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1399-3046.2007.00760.x","article-title":"Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery.","volume":"11","author":"Bilginer","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R80-10-20211004","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00467-007-0743-4","article-title":"Circulating calcification inhibitors and vascular properties in children after renal transplantation.","volume":"23","author":"van Summeren","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R81-10-20211004","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1600-6143.2005.00909.x","article-title":"Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial.","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"R82-10-20211004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00003086-199711000-00003","article-title":"The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis.","volume":"344","author":"Cui","year":"1997","journal-title":"Clin Orthop Relat Res"},{"key":"R83-10-20211004","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/hq1001.097781","article-title":"Effect of statins on bone mineral density and bone histomorphometry in rodents.","volume":"21","author":"Maritz","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R84-10-20211004","first-page":"235","article-title":"Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population Orthop Clin North A","volume":"40","author":"Ajmal","year":"2009","journal-title":"m"},{"key":"R85-10-20211004","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: Bisphosphonate use in childhood osteoporosis.","volume":"94","author":"Bachrach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R86-10-20211004","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1096\/fj.09-132548","article-title":"Retinoids inhibit differentiation of hematopoietic osteoclast progenitors.","volume":"23","author":"Conaway","year":"2009","journal-title":"FASEB J"},{"key":"R87-10-20211004","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1523-1755.2005.00339.x","article-title":"Parathyroid hormone and growth in children with chronic renal failure.","volume":"67","author":"Waller","year":"2005","journal-title":"Kidney Int"},{"key":"R88-10-20211004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"R89-10-20211004","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2215\/CJN.00330112","article-title":"The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.","volume":"8","author":"Bacchetta","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R90-10-20211004","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R91-10-20211004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00467-012-2270-1","article-title":"Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.","volume":"28","author":"Haffner","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R92-10-20211004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R93-10-20211004","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1096\/fj.10-172577","article-title":"Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling.","volume":"25","author":"Lisse","year":"2011","journal-title":"FASEB J"},{"key":"R94-10-20211004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1523-1755.2005.00087.x","article-title":"Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study.","volume":"67","author":"Schwarz","year":"2005","journal-title":"Kidney Int"},{"key":"R95-10-20211004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00467-007-0559-2","article-title":"Long-term outcome after renal transplantation in childhood.","volume":"24","author":"Rees","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R96-10-20211004","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s004670050483","article-title":"Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology.","volume":"12","author":"Guest","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R97-10-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-012-2293-7","article-title":"Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth.","volume":"28","author":"Mehls","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R98-10-20211004","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1755.2002.00489.x","article-title":"Recombinant human growth hormone postrenal transplantation in children: a randomized controlled study of the NAPRTCS.","volume":"62","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"R99-10-20211004","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00467-008-0849-3","article-title":"Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology.","volume":"23","author":"Berard","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R100-10-20211004","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e3181c1e042","article-title":"Maximizing growth in children after renal transplantation.","volume":"88","author":"Cochat","year":"2009","journal-title":"Transplantation"},{"key":"R101-10-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00467-012-2208-7","article-title":"Growth hormone improves growth in pediatric renal transplant recipients-a systemic review and meta-analysis of randomized controlled trials.","volume":"28","author":"Wu","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R102-10-20211004","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00467-010-1453-x","article-title":"Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers.","volume":"25","author":"Bacchetta","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R103-10-20211004","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","article-title":"Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.","volume":"27","author":"Cochat","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R104-10-20211004","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.109.5.909","article-title":"Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study.","volume":"109","author":"Furth","year":"2002","journal-title":"Pediatrics"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201310000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:35:03Z","timestamp":1633512903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201310000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283651b21","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}